Company Overview
Company Name
Anthos Therapeutics
Address
99 High Street, Boston, MA, 02110, United States
Website
anthostherapeutics.comAbout Anthos Therapeutics
Anthos Therapeutics is a Boston-based biopharmaceutical company focused on developing innovative treatments for atrial fibrillation and cancer-associated thrombosis. The company's lead candidate, abelacimab, is a novel anticoagulant that targets Factor XI, promising reduced bleeding risks compared to existing therapies.
Technologies Used
Key Decision Makers
| Name | Job Title | Contact | |
|---|---|---|---|
Deb Freedholm | Sr VP, Clinical Operations | LinkedIn Profile | |
Robin White | Lead Clinical Trial Manager | LinkedIn Profile |